Effect of actarit combination therapy in patients with active rheumatoid arthritis resistant to gold agents

Ryumachi

Volumn 41, Issue 3, 2001, Pages 635-645

  Sakurai, T ^a   Iso, T ^a   Inoue, H ^a   Sano, K ^a   Takeuchi, K ^a   Takagishi, K ^a  

^a MAEBASHI RED CROSS HOSPITAL   (Japan)

Author keywords

Actarit; Auranofin; Combination therapy; Gold sodium thiomalate; Rheumatoid arthritis

Indexed keywords

ACTARIT; GOLD DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; DRUG INDUCED DISEASE; DRUG MIXTURE; FEMALE; GRIP STRENGTH; HUMAN; JOINT STIFFNESS; MALE; RHEUMATOID ARTHRITIS;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AURANOFIN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENYLACETATES; TREATMENT OUTCOME;

EID: 0034924898     PISSN: 03009157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs
2. Practical results of treatment with disease-modifying antirheumatoid drugs
3. Clinical pharmacology of combination DMARD therapy in rheumatoid arthritis
4. Effect of gold sodiumthiomalate and its thiomalate component on the in vitro expression of endothelial cell adhesion molecules
5. Comparative pharma-cokinetics of parenteral and oral gold compounds
6. Biologic actions and pharmacokinetic studies of auranofin